Julia Ilyushenkova

Julia Ilyushenkova


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
VRVyacheslav Ryabov
Vyacheslav Ryabov
Trusov AndreyTrusov Andrey
Trusov Andrey
MKMaria Kercheva
Maria Kercheva
AGAleksandra Gombozhapova
Aleksandra Gombozhapova
JIJulia Ilyushenkova
Julia Ilyushenkova
SSSvetlana Ivanovna Sazonova
Svetlana Ivanovna Sazonova
Nuclear imaging modalities can detect somatostatin receptor type 2 (SSTR2) in vivo as a potential marker of local post-MI inflammation. SSTR2+ macrophages are thought to be the main substrate for SSTR-targeted radioimaging. However, the distribution of SSTR2+ cells in the MI patients’ myocardium is unknown. Using immunohistochemistry, we investigated the distribution of SSTR2+ cells in the myocardium of patients who died during the MI inflammatory phase (n = 7) compared to the control group of individuals with fatal trauma (n = 3). Inflammatory cellular landscapes evolve in a wave front-like pattern, so we divided the myocardium into histological zones: the infarct core (IC), the border zone (BZ), the remote zone (RZ), and the peri-scar zone (PSZ). The number of SSTR2+ neutrophils (NPs), SSTR2+ monocytes/macrophages (Mos/MPs), and SSTR2+ vessels were counted. In the myocardium of the control group, SSTR2+ NPs and SSTR2+ Mos/MPs were occasional, SSTR2+ vessels were absent. In the RZ, the picture was similar to the control group, but there was a lower number of SSTR2+ Mos/MPs in the RZ. In the PSZ, SSTR2+ vessel numbers were highest in the myocardium. In the IC, the median number of SSTR2+ NPs was 200 times higher compared to the RZ or control group myocardium, which may explain the selective uptake of SSTR-targeted radiotracers in the MI area during the inflammatory phase of MI.

1 December 2025 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
JIJulia Ilyushenkova
Julia Ilyushenkova
AMA. V. Mukhomedzyanov
A. V. Mukhomedzyanov
BKB. K. Kurbatov
B. K. Kurbatov
ASA. S. Slidnevskaya
A. S. Slidnevskaya
YVYu. V. Varlamova
Yu. V. Varlamova
SSS. I. Sazonova
S. I. Sazonova

1 January 2025 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
JIJulia Ilyushenkova
Julia Ilyushenkova
AMA. V. Mukhomedzyanov
A. V. Mukhomedzyanov
BKB. K. Kurbatov
B. K. Kurbatov
ASA. S. Slidnevskaya
A. S. Slidnevskaya
YVYu. V. Varlamova
Yu. V. Varlamova
SSS. I. Sazonova
S. I. Sazonova